News
Net loss increased to $ (9.1) million compared to $ (8.0) million as a result of the addition of NAYA Therapeutics and corresponding merger costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback